1joh: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Tag: Manual revert
 
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1joh.png|left|200px]]


<!--
==THE STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE-ACTIVE PEPTIDE==
The line below this paragraph, containing "STRUCTURE_1joh", creates the "Structure Box" on the page.
<StructureSection load='1joh' size='340' side='right'caption='[[1joh]], [[Resolution|resolution]] 1.40&Aring;' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[1joh]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Emericellopsis Emericellopsis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1JOH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1JOH FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.4&#8491;</td></tr>
-->
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=AIB:ALPHA-AMINOISOBUTYRIC+ACID'>AIB</scene>, <scene name='pdbligand=DIV:D-ISOVALINE'>DIV</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>, <scene name='pdbligand=MOH:METHANOL'>MOH</scene>, <scene name='pdbligand=PHL:L-PHENYLALANINOL'>PHL</scene>, <scene name='pdbligand=PRD_000161:Antiamoebin+1'>PRD_000161</scene></td></tr>
{{STRUCTURE_1joh|  PDB=1joh  |  SCENE=  }}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1joh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1joh OCA], [https://pdbe.org/1joh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1joh RCSB], [https://www.ebi.ac.uk/pdbsum/1joh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1joh ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
BACKGROUND: Antiamoebin is a member of the peptaibol family of polypeptides and has a unique antibiotic activity: it acts as an antiamoebic agent, but does not effectively haemolyze erythrocytes even though it does exhibit membrane-modifying activity. RESULTS: The structure of antiamoebin I has been determined by X-ray crystallography at 1.4 A resolution. The molecule forms a helical structure, which, as a result of the presence of a number of proline and hydroxyproline residues, has a deep bend in the middle. Circular dichroism spectroscopy, single-channel conductance studies and fluorescence diffusion studies suggest a mode of ion transport that is entirely different from that of the other two members of the peptaibol family (alamethicin and zervamicin) whose structures and functions have been examined in detail. CONCLUSIONS: The structure of the polypeptide has been determined and a functional model for its mode of action in membranes is presented. Although under some conditions antiamoebin may form ion channels, unlike the closely related alamethicin and zervamicin polypeptides, its major membrane-modifying activity appears to be as an ion carrier.


===THE STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE-ACTIVE PEPTIDE===
The structure and function of antiamoebin I, a proline-rich membrane-active polypeptide.,Snook CF, Woolley GA, Oliva G, Pattabhi V, Wood SF, Blundell TL, Wallace BA Structure. 1998 Jun 15;6(6):783-92. PMID:9655831<ref>PMID:9655831</ref>


 
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
<!--
</div>
The line below this paragraph, {{ABSTRACT_PUBMED_9655831}}, adds the Publication Abstract to the page
<div class="pdbe-citations 1joh" style="background-color:#fffaf0;"></div>
(as it appears on PubMed at http://www.pubmed.gov), where 9655831 is the PubMed ID number.
== References ==
-->
<references/>
{{ABSTRACT_PUBMED_9655831}}
__TOC__
 
</StructureSection>
==About this Structure==
[[1joh]] is a 2 chain structure of [[Ion channels]] with sequence from [http://en.wikipedia.org/wiki/Emericellopsis Emericellopsis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1JOH OCA].
 
==See Also==
*[[Ion channels]]
 
==Reference==
<ref group="xtra">PMID:9655831</ref><references group="xtra"/>
[[Category: Emericellopsis]]
[[Category: Emericellopsis]]
[[Category: Snook, C F.]]
[[Category: Large Structures]]
[[Category: Wallace, B A.]]
[[Category: Snook CF]]
[[Category: Antiamoebin]]
[[Category: Wallace BA]]
[[Category: Peptaibol]]
[[Category: Peptide antibiotic]]

Latest revision as of 12:37, 25 December 2024

THE STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE-ACTIVE PEPTIDETHE STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE-ACTIVE PEPTIDE

Structural highlights

1joh is a 2 chain structure with sequence from Emericellopsis. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 1.4Å
Ligands:, , , , , ,
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Publication Abstract from PubMed

BACKGROUND: Antiamoebin is a member of the peptaibol family of polypeptides and has a unique antibiotic activity: it acts as an antiamoebic agent, but does not effectively haemolyze erythrocytes even though it does exhibit membrane-modifying activity. RESULTS: The structure of antiamoebin I has been determined by X-ray crystallography at 1.4 A resolution. The molecule forms a helical structure, which, as a result of the presence of a number of proline and hydroxyproline residues, has a deep bend in the middle. Circular dichroism spectroscopy, single-channel conductance studies and fluorescence diffusion studies suggest a mode of ion transport that is entirely different from that of the other two members of the peptaibol family (alamethicin and zervamicin) whose structures and functions have been examined in detail. CONCLUSIONS: The structure of the polypeptide has been determined and a functional model for its mode of action in membranes is presented. Although under some conditions antiamoebin may form ion channels, unlike the closely related alamethicin and zervamicin polypeptides, its major membrane-modifying activity appears to be as an ion carrier.

The structure and function of antiamoebin I, a proline-rich membrane-active polypeptide.,Snook CF, Woolley GA, Oliva G, Pattabhi V, Wood SF, Blundell TL, Wallace BA Structure. 1998 Jun 15;6(6):783-92. PMID:9655831[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Snook CF, Woolley GA, Oliva G, Pattabhi V, Wood SF, Blundell TL, Wallace BA. The structure and function of antiamoebin I, a proline-rich membrane-active polypeptide. Structure. 1998 Jun 15;6(6):783-92. PMID:9655831

1joh, resolution 1.40Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA